Compare AGIO & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGIO | NBHC |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2013 | 2011 |
| Metric | AGIO | NBHC |
|---|---|---|
| Price | $37.22 | $37.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $46.00 | $44.00 |
| AVG Volume (30 Days) | ★ 1.0M | 430.4K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | $43,011,000.00 | ★ $47,100,000.00 |
| Revenue This Year | $229.47 | $25.73 |
| Revenue Next Year | $94.99 | $7.50 |
| P/E Ratio | ★ N/A | $36.57 |
| Revenue Growth | N/A | ★ 2.86 |
| 52 Week Low | $22.24 | $35.06 |
| 52 Week High | $46.00 | $47.28 |
| Indicator | AGIO | NBHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.97 | 39.03 |
| Support Level | $32.17 | $37.12 |
| Resistance Level | $44.09 | $42.66 |
| Average True Range (ATR) | 1.34 | 0.67 |
| MACD | 0.66 | 0.10 |
| Stochastic Oscillator | 98.33 | 58.61 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.